Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein

Cerebellum

Volumn 6, Issue 4, 2007, Pages 300-307

  Zühlke, Christine ^a   Bürk, Katrin ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Ataxia; Cerebellum; Repeat expansion; SCA17; TBP

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; GLUTAMINE; TATA BINDING PROTEIN;

ALLELE; ARTICLE; AUTOSOMAL INHERITANCE; BRAIN ATROPHY; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CHOREA; CLINICAL FEATURE; CODON; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DYSTONIA; GENE; GENE MUTATION; HUMAN; INVOLUNTARY MOVEMENT; MENTAL DISEASE; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; ONSET AGE; PENETRANCE; PRIORITY JOURNAL; PYRAMIDAL SIGN; SCA17 GENE; SPINOCEREBELLAR ATAXIA TYPE 17; SPINOCEREBELLAR DEGENERATION; SYMPTOM;

AGE OF ONSET; ALLELES; BASAL GANGLIA DISEASES; CEREBELLUM; COGNITION; DIAGNOSIS, DIFFERENTIAL; DNA; ELECTROENCEPHALOGRAPHY; GENETIC TESTING; GENOTYPE; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; MUTATION; PHENOTYPE; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 36549002245     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1080/14734220601136177     Document Type: Article

References (61)

1. Manto MU. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum. 2005;4:2-6.
2. Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F. Molecular genetics of hereditary spinocerebellar ataxia: Mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol. 2004;61:727-33.
3. Craig K, Keers SM, Walls TJ, Curtis A, Chinnery PF. Minimum prevalence of spinocerebellar ataxia 17 in the north east of England. J Neurol Sci. 2005;239:105-9.
4. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease? Hum Mol Genet. 1999;8:2047-53.
5. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Molec Genet. 2001;10:1441-8.
6. Zühlke C, Hellenbroich Y, Dalski A, Kononowa N, Hagenah J, Vieregge P, Riess O, Klein C, Schwinger E. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet. 2001;9:160-4.
7. Zühlke C, Gehlken U, Hellenbroich Y, Schwinger E, Bürk K. Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17? J Neurol. 2003;250:161-3.
8. Zühlke C, Spranger M, Spranger S, Voigt R, Lanz M, Gehlken U, Hinrichs F, Schwinger E. SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6. Eur J Hum Genet. 2003;11:629-32.
9. Fujigasaki H, Martin JJ, De Deyn PP, Camuzat A, Deffond D, Stevanin G, Dermaut B, Van Broeckhoven C, Durr A, Brice A. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain. 2001;124:939-1947.
10. De Michele G, Maltecca F, Carella M, Volpe G, Orio M, De Falco A, Gombia S, Servadio A, Casari G, Filla A, Bruni A. Dementia, ataxia, extrapyramidal features, and epilepsy: Phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci. 2003;24:166-7.
11. Maltecca F, Filla A, Castaldo I, Coppola G, Fragassi NA, Carella M, Bruni A, Cocozza S, Casari G, Servadio A, De Michele G. Intergenerational instability and marked anticipation in SCA-17. Neurology. 2003;61:1441-3.
12. Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Dürr A. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain. 2003;126:1599-603.
13. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schöls L, Riess O. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol. 2003;54:367-75.
14. Toyoshima Y, Yamada M, Onodera O, Shimohata M, Inenaga C, Fujita N, Morita M, Tsuji S, Takahashi H. SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol. 2004;55:281-6.
15. Günther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S. Basal ganglia involvement of a patient with SCA 17 - a new form of autosomal dominant spinocerebellar ataxia. J Neurol. 2004;251:896-7.
16. Hagenah JM, Zühlke C, Hellenbroich Y, Heide W, Klein C. Focal dystonia as presenting sign of SCA17. Mov Dis. 2004;19:217-20.
17. Bruni AC, Takahashi-Fujigasaki J, Maltecca F, Foncin JF, Servadio A, Casari G, D'Adamo P, Maletta R, Curcio SA, De Michele G, Filla A, El Hachimi KH, Duyckaerts C. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol. 2004;61:1314-20.
18. Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ. Spinocerebellar ataxia type 17: Extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord. 2005;20:1521-3.
19. Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, Wolters A, Kock N, Steinlechner S, Nagel M, Zühlke C, Nitschke MF, Brockmann K, Klein C, Rolfs A, Binkofski F. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain. 2006;129:2341-52.
20. Minnerop M, Joe A, Lutz M, Bauer P, Urbach H, Helmstaedter C, Reinhardt M, Klockgether T, Wüllner U. Putamen dopamine transporter and glucose metabolism are reduced in SCA17. Ann Neurol. 2005;58:490-1.
21. Salvatore E, Varrone A, Sansone V, Nolano M, Bruni AC, De Rosa A, Santoro L, Pappata S, Filla A, De Michele G. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. Mov Disord. 2006;21:872-5.
22. Bauer P, Laccone F, Rolfs A, Wüllner U, Bösch S, Peters H, Liebscher S, Scheible M, Epplen JT, Weber BH, Holinski-Feder E, Weirich-Schwaiger H, Morris-Rosendahl DJ, Andrich J, Riess O. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet. 2004;41:230-2.
23. Bürk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, Didierjan O, Brice A, Klockgether T. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;119:1497-505.
24. Hellenbroich Y, Bubel S, Pawlack H, Opitz S, Vieregge P, Schwinger E, Zühlke C. Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region. J Neurol. 2003;250:668-71.
25. Bürk K, Zühlke C, König IR, Ziegler A, Schwinger E, Globas C, Dichgans J, Hellenbroich Y. Spinocerebellar ataxia type 5 (SCA5): Clinical and molecular genetic features of a German kindred. Neurology. 2004;62:327-9.
26. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997;15:62-9.
27. Imbert G, Trottier Y, Beckmann J, Mandel JL. The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. Genomics. 1994;21:667-8.
28. Polymeropoulos MH, Rath DS, Xiao H, Merril CR. Trinucleotide repeat polymorphism at the human transcription factor IID gene. Nucleic Acids Res. 1991;19:4307.
29. Gostout B, Liu Q, Sommer SS. 'Cryptic' repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am J Hum Genet. 1993;52:1181-90.
30. Silveira I, Miranda C, Guimaraes L, Moreira MC, Alonso I, Mendonca P, Ferro A, Pinto-Basto J, Coelho J, Ferreirinha F, Poirier J, Parreira E, Vale J, Januario C, Barbot C, Tuna A, Barros J, Koide R, Tsuji S, Holmes SE, Margolis RL, Jardim L, Pandolfo M, Coutinho P, Sequeiros J. Trinucleotide repeats in 202 families with ataxia: A small expanded (CAG)n allele at the SCA17 locus. Arch Neurol. 2002;59:623-9.
31. Juvonen V, Hietala M, Kairisto V, Savontaus ML. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand. 2005;111:154-62.
32. Oda M, Maruyama H, Komure O, Morino H, Terasawa H, Izumi Y, Imamura T, Yasuda M, Ichikawa K, Ogawa M, Matsumoto M, Kawakami H. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol. 2004;61:209-12.
33. Zühlke C, Dalski A, Schwinger E, Finckh U. Spinocerebellar ataxia type 17: Report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes. BMC Med Genet. 2005;6:27.
34. Shatunov A, Fridman EA, Pagan FI, Leib J, Singleton A, Hallett M, Goldfarb LG. Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease. Clin Genet. 2004;66:496-501.
35. Goldfarb LG, Vasconcelos O, Platonov FA, Lunkes A, Kipnis V, Kononova S, Chabrashvili T, Vladimirtsev VA, Alexeev VP, Gajdusek DC. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol. 1996;39:500-6.
36. Choudhry S, Mukerji M, Srivastava AK, Jain S, Brahmachari SK. CAG repeat instability at SCA2 locus: Anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum Mol Genet. 2001;10:2437-46.
37. Zühlke C, Dalski A, Hellenbroich Y, Bubel S, Schwinger E, Bürk K. Spinocerebellar ataxia type 1 (SCA1): Phenotype-genotype correlation studies in intermediate alleles. Eur J Hum Genet. 2002;10:204-9.
38. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet. 1997;6:2005-10.
39. McNeil SM, Novelletto A, Srinidhi J, Barnes G, Kornbluth I, Altherr MR, Wasmuth JJ, Gusella JF, MacDonald ME, Myers RH. Reduced penetrance of the Huntington's disease mutation. Hum Mol Genet. 1997;6:775-9.
40. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S, Kakizuka A. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8:221-8.
41. van der Sluijs BM, van Engelen BG, Hoefsloot LH. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene. Hum Mutat. 2003;21:553.
42. Takiyama Y, Igarashi S, Rogaeva EA, Endo K, Rogaev EI, Tanaka H, Sherrington R, Sanpei K, Liang Y, Saito M. Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and caucasian subjects with Machado-Joseph disease. Hum Mol Genet. 1995;4:1137-46.
43. Lerer I, Merims D, Abeliovich D, Zlotogora J, Gadoth N. Machado-Joseph Disease: Correlation between clinical features, the CAG repeat length and homozygosity of the mutation. Eur J Hum Genet. 1996;4:3-7.
44. Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, Snodgrass SR, Shoulson I, Gomez F, Ramos Arroyo MA. Homozygotes in Huntington's disease. Nature. 1997;326:194-7.
45. Polo JM, Calleja J, Combarros O, Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain. 1991;114:855-66.
46. Maruyama H, Izumi Y, Morino H, Oda M, Toji H, Nakamura S, Kawakami H. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: Astudy of 1,286 Japanese patients. Am J Hum Genet. 2002;114:578-83.
47. Wu YR, Fung HC, Lee-Chen GJ, Gwinn-Hardy K, Ro LS, Chen ST, Hsieh-Li HM, Lin HY, Lin CY, Li SN, Chen CM. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm. 2005;112:539-46.
48. Hoffmann A, Sinn E, Yamamoto T, Wang J, Roy A, Horisoshi M, Roeder RG. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature. 1990;346:387-90.
49. Kao CC, Lieberman PM, Schmidt MC, Zhou Q, Pei R, Berk AJ. Cloning of a transcriptionally active human TATA binding factor. Science. 1990;248:1646-50.
50. Peterson MG, Tanese N, Pugh BF, Tjian R. Functional domains and upstream activation properties of cloned human TATA binding protein. Science. 1990;248:1625-30.
51. Purrello M, Pietro CD, Mirabile E, Rapisarda A, Rimini R, Tine A, Pavone L, Motta S, Grzeschik KH, Sichel G. Physical mapping at 6q27 of the locus for the TATA box-binding protein, the DNA-binding subunit of TFIID and a component of SL1 and TFIIIB, strongly suggests that it is single copy in the human genome. Genomics. 1994;22:94-100.
52. Veenstra GJC, Weeks DL, Wolffe AP. Distinct roles for TBP and TBP-like factor in early embryonic gene transcription in Xenopus. Science. 2000;290:2312-4.
53. Martianov I, Viville S, Davidson I. RNA polymerase II transcription in murine cells lacking the TATA binding protein. Science. 2002;298:1036-9.
54. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel JL. Polyglutamine expansion as a pathological epitope in Huntington' disease and four dominant cerebellar ataxias. Nature. 1995;378:403-6.
55. van Roon-Mom WM, Reid SJ, Jones AL, MacDonald ME, Faull RL, Snell RG. Insoluble TATA-binding protein accumulation in Huntington's disease cortex. Brain Res Mol Brain Res. 2002;109:1-10.
56. Reid SJ, van Roon-Mom WM, Wood PC, Rees MI, Owen MJ, Faull RL, Dragunow M, Snell RG. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease. Brain Res Mol Brain Res. 2004;125:120-8.
57. Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, Li SH, Hwang JC, Fang K, Hsieh-Li HM, Li ML, Tung LC, Su MT, Lu KT, Lee-Chen GJ. Genetic testing in spinocerebellar ataxia in Taiwan: Expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet. 2004;65:209-214.
58. Rubinsztein DC, Leggo J, Crow TJ, DeLisi LE, Walsh C, Jain S, Paykel ES. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder. Am J Hum Genet. 1996;67:495-8.
59. Jones AL, Middle F, Guy C, Spurlock G, Cairns NJ, McGuffin P, Craddock N, Owen M, O'Donovan MC. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Mol Psychiatry. 1997;2:478-82.
60. WFN&IHA, Guidelines for the molecular genetics predictive test in Huntington's disease. Med Genet. 1994;31:555-9.
61. Guarente L, Bermingham-McDonogh O. Conservation and evolution of transcriptional mechanisms in eukaryotes. Trends Genet. 1992;8:27-32.